a2z Radiology AI vs OpenAI
Side-by-side comparison of AI visibility scores, market position, and capabilities
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
About
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
GPT-5 and o3 model family at $25B+ ARR; $840B post-money valuation (Feb 2026 round); ChatGPT 1B+ users; largest private fundraise in history ($110B). Competing with Anthropic Claude 4, Google Gemini 3, Meta Llama 4.
About
OpenAI is a San Francisco-based artificial intelligence company developing and deploying large-scale AI systems — including GPT-4o, o1 reasoning models, DALL-E 3 image generation, Sora video generation, and the Whisper speech recognition model — through the ChatGPT consumer product and OpenAI API for developers and enterprise customers. Founded in 2015 as a nonprofit by Sam Altman, Elon Musk, Greg Brockman, and others and restructured into a capped-profit company, OpenAI raised $157 billion in total funding including a $6.6 billion round in October 2024 at a $157 billion valuation and a $40 billion round from SoftBank in 2025, generating $3.7 billion in annualized revenue in 2024 with 400 million weekly ChatGPT users.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.